From Medscape Ophthalmology

Coverage from the

American Society of Retina Specialists (ASRS) 2024 Annual Meeting

July 17 - 20, 2024; Stockholm, Sweden

July 17 - 20, 2024 Stockholm, Sweden

Conference News

ASRS 2024 More Anti-VEGF Injections Might Increase Visual Acuity
Medscape Medical News, July 24, 2024
ASRS 2024 Are GLP-1s Bad for Retinas?
Medscape Medical News, July 23, 2024
ASRS 2024 Novel Gene Therapy Safe for Retinitis Pigmentosa
Medscape Medical News, July 23, 2024
ASRS 2024 Here's How to Have 'Greener' Intravitreal Injections
Medscape Medical News, July 22, 2024

ASRS 2024 Retinal Detachment Still Sticky Issue for Stickler Syndrome
Medscape Medical News, July 19, 2024
ASRS 2024 Eyes With IOLs Do Worse With In-Office Retina Repair
Medscape Medical News, July 19, 2024
ASRS 2024 Ixo-vec Gene Therapy Reduces Anti-VEGF Injections in nAMD
Medscape Medical News, July 18, 2024

Medscape Ophthalmology©

Popular News from ASRS 2023

Methotrexate Could Reduce the Risk for Retinal Redetachment Intravitreal injections with methotrexate appear to reduce scar formation after retinal reattachment even in patients with proliferative diabetic retinopathy.
Medscape Medical News, Jul 20, 2022
Metformin Shows Potential to Prevent Macular Degeneration People prescribed the diabetes drug metformin may be less likely to develop age-related macular degeneration.
Medscape Medical News, Jul 18, 2022
Light Treatment Shows Promise in Dry Macular Degeneration Photobiomodulation may be the most promising treatment yet for dry age-related macular degeneration.
Medscape Medical News, Jul 21, 2022

Previous Coverage

Related Resources

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC. This website also contains material copyrighted by 3rd parties.